Facebook
Twitter
LinkedIn
Forward
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition.
|
Weight stigma is an often-overlooked contributor to poor patient engagement and weight gain over time.
|
Learn the evidence for use of meal replacements and medically tailored meals in the treatment of obesity and related adiposity related complications.
|
This roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.
|
In 2020, the U.S. Census Bureau released estimates showing the 65-and-older population has grown rapidly since 2010.
|
Recorded during Obesity Medicine 2022. CME/CE Expiration Date: 6/19/25
|
|
This interactive session will explore the complex relationship of how our mood affects our food choices and vice versa.
|
This session will discuss the benefits of a carbohydrate-restricted diet on chronic diseases such as type 2 diabetes with special attention on the role of nutrition in wound healing.
|
The gut microbiome is recognized as an important factor in obesity. This webinar will review the interconnection between obesity and the gut microbiome.
|